Frost & Sullivan Manufacturing

JUNE 16, 2022

June 16, 2022- Frost & Sullivan’s recent analysis, Global Pharmaceuticals Outlook , finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value chain. Global Pharmaceuticals Outlook, 2022. San Antonio, TX. growth, garnering $1.48

Pharmaceutical 52

Pharmaceutical Artificial Intelligence Value chain Supply Chain 52

Frost & Sullivan Manufacturing

MARCH 14, 2024

Compression of Value Chains: Direct-to-consumer genetic testing services – Companies like Nebula Genomics simplify the customer journey by providing direct access to genetic testing without intermediaries. By compressing value chains, these clinics will enhance efficiency and improve access to essential healthcare services.

Value chain 52

Value chain Pharmaceutical Supply Chain Artificial Intelligence 52

Frost & Sullivan Manufacturing

AUGUST 29, 2024

As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% increase from 2022. However, the pharma/biopharma industry overall shows stagnant R&D activity. Total R&D expenditure is approximately $276.81 billion, with a modest 2.5% growth from 2023 to 2024.

Pharmaceutical 52

Pharmaceutical Artificial Intelligence Value chain Compliance 52

Frost & Sullivan Manufacturing

JUNE 4, 2024

Artificial intelligence (AI) is driving this revolution by unlocking the potential of Precision Health through vast data integration, propelling drug discovery, development, and elevating patient care.

Artificial Intelligence 52

Artificial Intelligence Value chain Pharmaceutical 52

Frost & Sullivan Manufacturing

OCTOBER 9, 2024

Bosch Service Solutions is a premier provider of technology-based services that offers innovative solutions in customer experience, mobility, monitoring, and business services based on its highly advanced intelligent automation platform. Bosch Service Solutions provides its services in 60 countries and in more than 40 languages.

Automation 59

Automation Artificial Intelligence Value chain Pharmaceutical 59

Frost & Sullivan Manufacturing

SEPTEMBER 4, 2024

The rise of nutricosmetics, where nutrition meets cosmetics, and cosmeceuticals, which blend cosmetics with pharmaceuticals, epitomizes this transformative shift. What growth avenues is your company focusing on to secure a competitive edge in the evolving beauty and wellness ecosystem?

Supply Chain 52

Supply Chain 3D printing Artificial Intelligence Value chain 52

E&T

JANUARY 19, 2023

At the same time, early detection is critical, particularly in regulated industries such as pharmaceuticals or food and beverage, to avoid the accumulation of additional costs and production time spent on additional units that share the defect. It is critical to consider the entire lifecycle, not just internal operations.

Manufacturing 59

Manufacturing Supply Chain Artificial Intelligence Logistics 59